- Home
- TRNR vs KTTA Comparison
TRNR vs KTTA Comparison
Compare TRNR & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNR
- KTTA
- Stock Information
- Founded
- TRNR 2017
- KTTA 2020
- Country
- TRNR United States
- KTTA United States
- Employees
- TRNR N/A
- KTTA N/A
- Industry
- TRNR Consumer Electronics/Appliances
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- TRNR Technology
- KTTA Health Care
- Exchange
- TRNR Nasdaq
- KTTA Nasdaq
- Market Cap
- TRNR 3.3M
- KTTA 3.2M
- IPO Year
- TRNR 2023
- KTTA 2021
- Fundamental
- Price
- TRNR $2.04
- KTTA $2.12
- Analyst Decision
- TRNR
- KTTA
- Analyst Count
- TRNR 0
- KTTA 0
- Target Price
- TRNR N/A
- KTTA N/A
- AVG Volume (30 Days)
- TRNR 90.4K
- KTTA 37.8K
- Earning Date
- TRNR 03-31-2025
- KTTA 03-28-2025
- Dividend Yield
- TRNR N/A
- KTTA N/A
- EPS Growth
- TRNR N/A
- KTTA N/A
- EPS
- TRNR N/A
- KTTA N/A
- Revenue
- TRNR $3,180,000.00
- KTTA N/A
- Revenue This Year
- TRNR $1,543.45
- KTTA N/A
- Revenue Next Year
- TRNR $54.84
- KTTA N/A
- P/E Ratio
- TRNR N/A
- KTTA N/A
- Revenue Growth
- TRNR 226.82
- KTTA N/A
- 52 Week Low
- TRNR $1.85
- KTTA $2.03
- 52 Week High
- TRNR $4,760.00
- KTTA $9.25
- Technical
- Relative Strength Index (RSI)
- TRNR 27.86
- KTTA 30.89
- Support Level
- TRNR $2.34
- KTTA $2.38
- Resistance Level
- TRNR $2.55
- KTTA $2.62
- Average True Range (ATR)
- TRNR 0.19
- KTTA 0.17
- MACD
- TRNR 0.02
- KTTA -0.03
- Stochastic Oscillator
- TRNR 19.59
- KTTA 12.28
About TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.